In a laboratory, two identical creams are placed on a person’s skin. One is described as a strong pain reliever. Later, the same heat stimulus can be felt as less painful beneath that cream than beneath the one presented as ordinary. The cream has no active analgesic ingredient, but the reported difference can be real. Researchers have observed such effects alongside changes in brain activity related to pain processing.¹
That result is often flattened into the phrase “it was only a placebo”. The word only misleads. Pain is a genuine experience produced by a nervous system, and that system takes account of context, learning and expectation as well as signals from the body. A change in pain does not mean that an injury was imagined. It means the experience is open to modulation.
The brain does more than receive a signal
Pain is not a simple meter reading sent unchanged from a damaged part of the body. Nerves carry information, while the brain helps determine what that information means and how strongly it is experienced. Attention, previous experience and the expectation of relief can influence that process. Reviews of placebo analgesia describe both psychological mechanisms and neural pathways involved in this modulation.²
Imagine hearing a sudden noise in a room you believe is safe, then hearing the same noise when you believe someone is breaking in. The sound can be identical while the response differs. Pain is more complex than that analogy, and it should not be reduced to an attitude. It does, however, show why context can change a real experience without changing the initial stimulus.
Treatment brings a powerful context. A clinician’s explanation, the ritual of receiving care, the appearance of a medicine and memories of previous relief can all help form expectations. The US National Center for Complementary and Integrative Health describes a placebo effect as a beneficial outcome arising from anticipation of help and notes that a care provider’s interaction may contribute.³
Expectation and learning can take different routes
One pathway involves expectation: a person believes that relief is coming, and the nervous system engages processes that alter pain. In some experiments, this includes the body’s own opioid system. Evidence includes studies in which naloxone, a drug that blocks opioid receptors, reduces or reverses certain placebo analgesic responses.²,⁴ That does not mean every placebo effect is an opioid effect, or that an inert pill itself contains an analgesic.
Learning is another route. If a particular cream, setting or procedure has repeatedly coincided with less pain, the body may respond to those cues later. In the cream experiment described above, volunteers were first conditioned by pairing one cream with a lower heat stimulus. When both sites later received the same stimulus, the placebo-labelled site was rated as less painful. A study reported both the changed ratings and reduced activity in several pain-related brain measures.¹
That study also found that naloxone did not remove the effect in its experimental conditions, suggesting that the conditioned response did not depend on the same opioid pathway identified in some other work.¹ The findings are a useful warning against a single tidy explanation. Placebo analgesia is a name for a set of context-dependent effects, not one chemical switch.
What a pain rating can and cannot prove
Researchers often measure pain by asking people how much it hurts, because the felt experience is central to what pain is. That does not make every study easy to interpret. People’s reports can be affected by how questions are asked, by a wish to please an investigator, or by natural improvement over time. Some studies also track neural activity or use designs that compare a placebo with no treatment, helping separate effects of the treatment ritual from other changes.
A Cochrane review of trials comparing placebo interventions with no treatment found no major health benefit across clinical conditions in general. For pain, it found a modest average effect on reported outcomes, with results ranging from negligible to clinically important between studies. The review also cautioned that reporting bias can be difficult to disentangle from the effect.⁵ Both sides of that conclusion matter: placebo analgesia can be genuine, and its size should not be exaggerated.
Nor does reduced pain necessarily mean that the cause has gone away. A person may feel less pain while a fracture, infection or other condition still needs assessment and treatment. Pain can be useful information, even though it is not a perfect measure of tissue damage. The fact that context changes pain is therefore a reason to take the whole experience seriously, not a reason to dismiss medical causes.
Placebo research has one constructive lesson for ordinary care: clear communication, trust and supportive attention can be part of the experience of treatment. It does not follow that clinicians should deceive patients or replace effective care with inert pills. Even open-label placebos, where people know what they are receiving, are an active area of research rather than a universal prescription.⁴
The puzzling cream experiment becomes less mysterious when pain is understood as the nervous system’s interpretation of a situation. Incoming signals matter enormously; so do the brain’s predictions and learned associations. A placebo can sometimes change that interpretation enough to change how pain feels. The underlying person, and the pain they report, remain entirely real.